<DOC>
	<DOCNO>NCT02325674</DOCNO>
	<brief_summary>Post Authorisation Safety Registry US patient Generalised Lipodystrophy treat Metreleptin</brief_summary>
	<brief_title>Post Authorisation Safety Registry US Patients With Generalised Lipodystrophy Treated With Metreleptin</brief_title>
	<detailed_description>Post Authorisation Safety Registry US patient Generalised Lipodystrophy treat Metreleptin . This registry add knowledge metreleptin gain clinical trial provide information incidence rate acute pancreatitis , hypoglycemia , hypersensitivity lymphoma patient treat metreleptin routine clinical practice .</detailed_description>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Lipodystrophy , Congenital Generalized</mesh_term>
	<criteria>Patients treat metreleptin part clinical care Patients provide write consent Patient receive metreleptin part clinical trial expend access include compassionate use Patients currently treat investigational agent part clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Lipodystrophy</keyword>
	<keyword>Metreleptin Registry</keyword>
</DOC>